Concepedia
Statistics
Publications
7
Citations
235
H-Index
Active since
2019
Affiliations
Massachusetts General Hospital(Current)
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
University of Virginia
RTI Health Solutions
Merck & Co., Inc., Rahway, NJ, USA (United States)
Nifasha Rusibamayila is an author at Massachusetts General Hospital specializing in medicine, oncology, and renal disease.
Publications per year
2019–2022
Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease
Meghan E. Sise, Donald F. Chute, Yaa Oppong et al. · Kidney International · 2019 · 63 citations · Full text
Medicine, Nephrology, Pharmacotherapy +13
Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors
Harish Seethapathy, Nifasha Rusibamayila, Donald F. Chute et al. · Nephrology Dialysis Transplantation · 2020 · 60 citations · Full text
Medicine, Immunology, Oncology +15
Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza
Ian A. Strohbehn, Sophia Zhao, Harish Seethapathy et al. · Kidney International Reports · 2021 · 45 citations · Full text
Medicine, Infectious Diseases, Nephrology +14
Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib
Harish Seethapathy, Meghan Lee, Ian A. Strohbehn et al. · Nephrology Dialysis Transplantation · 2020 · 22 citations · Full text
Medicine, Nephrology, Pharmacology +16
Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors
Harish Seethapathy, Sarah E. Street, Ian A. Strohbehn et al. · European Journal of Cancer · 2021 · 16 citations
Medicine, Immunology, Oncology +17
1–5 of 7